CVA Family Office’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124K | Sell |
231
-15
| -6% | -$8.05K | 0.02% | 371 |
|
|
2025
Q1 | $103K | Buy |
246
+11
| +5% | +$4.62K | 0.02% | 385 |
|
|
2024
Q4 | $97.2K | Buy |
235
+28
| +14% | +$11.6K | 0.02% | 398 |
|
|
2024
Q3 | $105K | Buy |
207
+8
| +4% | +$4.04K | 0.02% | 361 |
|
|
2024
Q2 | $97K | Buy |
199
+3
| +2% | +$1.46K | 0.02% | 361 |
|
|
2024
Q1 | $106K | Buy |
196
+1
| +0.5% | +$540 | 0.02% | 344 |
|
|
2023
Q4 | $108K | Buy |
+195
| New | +$108K | 0.02% | 326 |
|
|
2023
Q3 | – | Sell |
-200
| Closed | -$100K | – | 566 |
|
|
2023
Q2 | $100K | Sell |
200
-3
| -1% | -$1.51K | 0.02% | 311 |
|
|
2023
Q1 | $102K | Buy |
203
+13
| +7% | +$6.5K | 0.02% | 307 |
|
|
2022
Q4 | $77.5K | Sell |
190
-25
| -12% | -$10.2K | 0.02% | 322 |
|
|
2022
Q3 | $70K | Buy |
215
+135
| +169% | +$44K | 0.02% | 297 |
|
|
2022
Q2 | $28K | Sell |
80
-45
| -36% | -$15.8K | 0.01% | 471 |
|
|
2022
Q1 | $68K | Sell |
125
-69
| -36% | -$37.5K | 0.02% | 331 |
|
|
2021
Q4 | $128K | Buy |
+194
| New | +$128K | 0.03% | 209 |
|
|
2021
Q3 | – | Sell |
-194
| Closed | -$123K | – | 592 |
|
|
2021
Q2 | $123K | Buy |
194
+129
| +198% | +$81.8K | 0.04% | 211 |
|
|
2021
Q1 | $32K | Buy |
+65
| New | +$32K | 0.01% | 332 |
|